Annual Cash & Cash Equivalents
$293.81 M
+$5.78 M+2.01%
31 December 2023
Summary:
Astrana Health annual cash & cash equivalents is currently $293.81 million, with the most recent change of +$5.78 million (+2.01%) on 31 December 2023. During the last 3 years, it has risen by +$60.71 million (+26.04%). ASTH annual cash & cash equivalents is now at all-time high.ASTH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$347.99 M
+$22.68 M+6.97%
30 September 2024
Summary:
Astrana Health quarterly cash and cash equivalents is currently $347.99 million, with the most recent change of +$22.68 million (+6.97%) on 30 September 2024. Over the past year, it has increased by +$74.05 million (+27.03%). ASTH quarterly cash and cash equivalents is now at all-time high.ASTH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASTH Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.0% | +27.0% |
| 3 y3 years | +26.0% | +49.3% |
| 5 y5 years | +184.7% | +237.2% |
ASTH Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.0% | at high | +89.1% |
| 5 y | 5 years | at high | +184.7% | at high | +330.2% |
| alltime | all time | at high | at high |
Astrana Health Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $347.99 M(+7.0%) |
| June 2024 | - | $325.31 M(-2.8%) |
| Mar 2024 | - | $334.80 M(+14.0%) |
| Dec 2023 | $293.81 M(+2.0%) | $293.81 M(+7.3%) |
| Sept 2023 | - | $273.94 M(-6.8%) |
| June 2023 | - | $293.92 M(+7.0%) |
| Mar 2023 | - | $274.61 M(-4.7%) |
| Dec 2022 | $288.03 M(+23.6%) | - |
| Dec 2022 | - | $288.03 M(+56.5%) |
| Sept 2022 | - | $184.02 M(-21.4%) |
| June 2022 | - | $234.22 M(-1.6%) |
| Mar 2022 | - | $237.94 M(+2.1%) |
| Dec 2021 | $233.10 M(+20.5%) | $233.10 M(+13.8%) |
| Sept 2021 | - | $204.77 M(+15.5%) |
| June 2021 | - | $177.29 M(-13.9%) |
| Mar 2021 | - | $205.88 M(+6.4%) |
| Dec 2020 | $193.47 M(+87.5%) | $193.47 M(+16.5%) |
| Sept 2020 | - | $166.08 M(+8.9%) |
| June 2020 | - | $152.44 M(+88.5%) |
| Mar 2020 | - | $80.89 M(-21.6%) |
| Dec 2019 | $103.19 M(-3.5%) | $103.19 M(-55.2%) |
| Sept 2019 | - | $230.30 M(+336.8%) |
| June 2019 | - | $52.73 M(-43.3%) |
| Mar 2019 | - | $93.01 M(-13.0%) |
| Dec 2018 | $106.89 M(+7.2%) | $106.89 M(-10.8%) |
| Sept 2018 | - | $119.78 M(+18.4%) |
| June 2018 | - | $101.13 M(-2.5%) |
| Mar 2018 | - | $103.73 M(+243.4%) |
| Dec 2017 | $99.75 M(+1051.3%) | - |
| Sept 2017 | - | $30.20 M(-3.2%) |
| June 2017 | - | $31.21 M(+260.2%) |
| Mar 2017 | $8.66 M(-6.5%) | $8.66 M(+117.2%) |
| Dec 2016 | - | $3.99 M(+5.1%) |
| Sept 2016 | - | $3.79 M(-41.7%) |
| June 2016 | - | $6.51 M(-29.8%) |
| Mar 2016 | $9.27 M(+84.9%) | $9.27 M(+99.6%) |
| Dec 2015 | - | $4.64 M(+18.3%) |
| Sept 2015 | - | $3.92 M(+0.9%) |
| June 2015 | - | $3.89 M(-22.4%) |
| Mar 2015 | $5.01 M | $5.01 M(-27.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $6.95 M(+76.0%) |
| Sept 2014 | - | $3.95 M(-31.5%) |
| June 2014 | - | $5.76 M(+297.0%) |
| Mar 2014 | $6.83 M(+370.7%) | - |
| Jan 2014 | $1.45 M(+23.3%) | $1.45 M(+43.4%) |
| Oct 2013 | - | $1.01 M(-19.2%) |
| July 2013 | - | $1.25 M(-20.5%) |
| Apr 2013 | - | $1.58 M(+33.9%) |
| Jan 2013 | $1.18 M(+615.8%) | $1.18 M(+134.9%) |
| Oct 2012 | - | $501.00 K(+93.4%) |
| July 2012 | - | $259.10 K(+33.6%) |
| Apr 2012 | - | $193.90 K(+17.9%) |
| Jan 2012 | $164.40 K(-58.6%) | $164.40 K(-34.2%) |
| Oct 2011 | - | $249.70 K(-27.2%) |
| July 2011 | - | $343.20 K(+21.7%) |
| Apr 2011 | - | $281.90 K(-29.0%) |
| Jan 2011 | $397.10 K(-40.3%) | $397.10 K(-20.8%) |
| Oct 2010 | - | $501.60 K(-6.1%) |
| July 2010 | - | $534.30 K(+5.9%) |
| Apr 2010 | - | $504.50 K(-24.2%) |
| Jan 2010 | $665.70 K(+690.6%) | $665.70 K(-22.9%) |
| Oct 2009 | - | $863.40 K(+851.9%) |
| July 2009 | - | $90.70 K(+53.2%) |
| Apr 2009 | - | $59.20 K(-29.7%) |
| Jan 2009 | $84.20 K(>+9900.0%) | $84.20 K(-43.1%) |
| Oct 2008 | - | $148.10 K(+63.6%) |
| July 2008 | - | $90.50 K(>+9900.0%) |
| June 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(-100.0%) |
| Mar 2005 | - | $300.00(+200.0%) |
| Dec 2004 | $100.00(-75.0%) | $100.00(0.0%) |
| Sept 2004 | - | $100.00(-50.0%) |
| June 2004 | - | $200.00(-33.3%) |
| Mar 2004 | - | $300.00 |
| Dec 2003 | $400.00 | - |
FAQ
- What is Astrana Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Astrana Health?
- What is Astrana Health annual cash & cash equivalents year-on-year change?
- What is Astrana Health quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Astrana Health?
- What is Astrana Health quarterly cash and cash equivalents year-on-year change?
What is Astrana Health annual cash & cash equivalents?
The current annual cash & cash equivalents of ASTH is $293.81 M
What is the all time high annual cash & cash equivalents for Astrana Health?
Astrana Health all-time high annual cash & cash equivalents is $293.81 M
What is Astrana Health annual cash & cash equivalents year-on-year change?
Over the past year, ASTH annual cash & cash equivalents has changed by +$5.78 M (+2.01%)
What is Astrana Health quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ASTH is $347.99 M
What is the all time high quarterly cash and cash equivalents for Astrana Health?
Astrana Health all-time high quarterly cash and cash equivalents is $347.99 M
What is Astrana Health quarterly cash and cash equivalents year-on-year change?
Over the past year, ASTH quarterly cash and cash equivalents has changed by +$74.05 M (+27.03%)